← Leaderboards
William Austin O'Brien
University Of Texas Medical Br Galveston
$7,154,790
Attributed
$7,154,790
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$7,154,790 · 16
By mechanism
U01$3,636,275 · 1
R01$2,225,331 · 3
R21$480,575 · 2
R43$430,933 · 1
R56$372,910 · 1
M01$6,900 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Miles W. Cloyd$4,809,767
- Werner A Braun$5,118,291
- Daryl T Lau$5,136,284
- Ned Snyder$107,011
- Lawrence R Stanberry$4,793,012
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsMacrophageHuman TissueBiological Signal TransductionInstitutionNeurotransmitter TransportTissue /Cell CultureAids Dementia ComplexResearch PersonnelHippocampusPostmortemLaboratory RatNeurotransmitter MetabolismNeural TransmissionFundingArachidonatePlatelet Activating FactorElectrophysiologyProstaglandin EGlutamate ReceptorGlutamatesGrantSynapsesAids Therapy
Grant awards (24)
FINITE ELEMENT SIMULATION OF SOUND WAVE PROPAGATION INTO THE HUMAN HEAD$1,095
P41 · FY2010 · RR · contact PI
Characterization of Cellular Proteins Involved in HIV Infection$430,933
R43 · FY2009 · AI · contact PI
FINITE ELEMENT SIMULATION OF SOUND WAVE PROPAGATION INTO THE HUMAN HEAD$771
P41 · FY2009 · RR · contact PI
ADULT AIDS CLINICAL TRIAL UNIT$456,251
U01 · FY2007 · AI · contact PI
ACTG 5178: SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS$1,325
M01 · FY2007 · RR · contact PI
ADULT AIDS CLINICAL TRIAL UNIT$623,323
U01 · FY2006 · AI · contact PI
Role of Tetraspan Glycoproteins (CD63) in HIV Entry$372,910
R56 · FY2006 · AI · contact PI
Role of Tetraspan Glycoproteins (CD63) HIV Replication$372,910
R01 · FY2006 · HL · contact PI
ACTG A5223: SEX DIFFERENCES IN LOPINAVIR/RITONAVIR PHARMACOKINETICS AMONG$1,436
M01 · FY2006 · RR · contact PI
ACTG 5178: SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS$1,436
M01 · FY2006 · RR · contact PI
ACTG A5142: A PHASE III, RANDOMIZED, OPEN-LABEL COMPARISON OF LOPINAVIR/$717
M01 · FY2006 · RR · contact PI
ADULT AIDS CLINICAL TRIAL UNIT$1,314,868
U01 · FY2005 · AI
Role of Tetraspan Glycoproteins (CD63) in HIV Entry$335,250
R01 · FY2005 · AI
ACTG A5210: A PHASE IB/IIA DOSE-FINDING SAFETY AND ACTIVITY STUDY OF AMD 11070$640
M01 · FY2005 · RR
ADULT AIDS CLINICAL TRIAL UNIT$1,241,833
U01 · FY2004 · AI
Role of Tetraspan Glycoproteins (CD63) in HIV Entry$335,250
R01 · FY2004 · AI
ACTG A5143: A RANDOMIZED, COMPARATIVE STUDY OF LOPINAVIR/RITONAVIR VERSUS$1,346
M01 · FY2004 · RR
Role of Tetraspan Glycoproteins (CD63) in HIV Entry$331,943
R01 · FY2003 · AI
LIPID MEDIATORS IN HIV NEUROTRANSMITTER DYSFUNCTION$324,547
R01 · FY2002 · NS
HIV MACROPHAGE TROPISM$294,325
R21 · FY2001 · AI
LIPID MEDIATORS IN HIV NEUROTRANSMITTER DYSFUNCTION$247,512
R01 · FY2001 · NS
BLOCKADE OF CD8+ T CELL DEATH BY CXCR4 INHIBITORS$186,250
R21 · FY2001 · AI
LIPID MEDIATORS IN HIV NEUROTRANSMITTER DYSFUNCTION$34,911
R01 · FY2001 · NS
LIPID MEDIATORS IN HIV NEUROTRANSMITTER DYSFUNCTION$243,008
R01 · FY2000 · NS